Study of XL647 Administered Orally Daily to Patients With Solid Tumors
Clinical trial NCT00336765 · COMPLETED
Trial details
- NCT number
- NCT00336765
- Sponsor
- Kadmon Corporation, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2010-08-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.